Trial intelligence / Profile preview

NovoSeven in Stanford type A acute aortic dissection surgery

jRCTs031250287Completed

Sponsor
University of Tsukuba Hospital
Start
Aug 2025
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of coagulation factor VIIa in aortic dissection, sponsored by University of Tsukuba Hospital. Primary endpoint: Time from cardiopulmonary bypass withdrawal to the end of surgery. Started Aug 2025; status: completed.

02

Drugs

coagulation factor VIIa
03

Conditions

aortic dissection

Beyond the preview

Go deeper on jRCTs031250287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031250287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call